oxonic acid has been researched along with Carcinoma, Epidermoid in 185 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study evaluated long-term outcomes for patients who received adjuvant gemcitabine plus S-1 chemotherapy after resection for pancreatic carcinoma." | 9.16 | Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. ( Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Nakashima, A; Sudo, T; Sueda, T; Uemura, K, 2012) |
| "In advanced esophageal squamous cell carcinoma (ESCC), paclitaxel plus cisplatin are considered as active and tolerable." | 7.85 | A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma. ( Jin, SL; Liu, YY; Luo, SX; Tang, H; Wang, HY; Yang, SJ; Yao, SN; Yao, ZH; Zhao, Y; Zhou, WP, 2017) |
| "Although standard chemotherapy for esophageal cancer patients is fluorouracil and cisplatin, the prognosis is still unsatisfactory." | 6.82 | Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma. ( Matsuhashi, N; Okumura, N; Tanahashi, T; Tanaka, Y; Yamaguchi, K; Yoshida, K, 2016) |
| "In Japan, esophagectomy after two courses of 5-fluorouracil plus cisplatin is regarded a standard strategy for treating stage II or III esophageal squamous cell carcinoma (ESCC)." | 5.34 | An Open-Label Single-Arm Phase II Study of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus. ( Hattori, N; Hayashi, M; Iwata, N; Kanda, M; Kodera, Y; Koike, M; Nakayama, G; Omae, K; Shimizu, D; Tanaka, C; Yamada, S, 2020) |
| "This study evaluated long-term outcomes for patients who received adjuvant gemcitabine plus S-1 chemotherapy after resection for pancreatic carcinoma." | 5.16 | Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. ( Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Nakashima, A; Sudo, T; Sueda, T; Uemura, K, 2012) |
| "In advanced esophageal squamous cell carcinoma (ESCC), paclitaxel plus cisplatin are considered as active and tolerable." | 3.85 | A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma. ( Jin, SL; Liu, YY; Luo, SX; Tang, H; Wang, HY; Yang, SJ; Yao, SN; Yao, ZH; Zhao, Y; Zhou, WP, 2017) |
| "The proportion of elderly patients in esophageal cancer is now growing, but there is a lack of evidence in term of treatment standard for this group of patients, which is what we aim to obtain through this prospective phase III study." | 2.90 | A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol. ( Chang, X; Chen, J; Deng, L; Ge, X; Han, C; Li, C; Liang, J; Lin, Y; Ni, W; Pang, Q; Sun, X; Wang, L; Wang, P; Wang, W; Wang, X; Xiao, Z; Zhang, W; Zhao, Y; Zhou, Z, 2019) |
| "Sixteen patients (48." | 2.87 | A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease. ( Atagi, S; Azuma, M; Goto, H; Haku, T; Hanibuchi, M; Kakiuchi, S; Kawano, H; Kondo, M; Nishioka, Y; Nokihara, H; Ogushi, F; Otsuka, K; Sakaguchi, S; Shimizu, E; Toyoda, Y, 2018) |
| "Although standard chemotherapy for esophageal cancer patients is fluorouracil and cisplatin, the prognosis is still unsatisfactory." | 2.82 | Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma. ( Matsuhashi, N; Okumura, N; Tanahashi, T; Tanaka, Y; Yamaguchi, K; Yoshida, K, 2016) |
| " Adverse reactions included grade I/II radiation esophagitis and pneumonitis, with good tolerance." | 2.82 | Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients. ( Li, QL; Qiu, MQ; Wang, T; Zhang, SF, 2016) |
| "Patients with stage II, III, or IVA esophageal cancer were randomly allocated to either 2 cycles of ICT (oxaliplatin 130 mg/m(2) on day 1 and S1 at 40 mg/m(2) twice daily on days 1-14, every 3 weeks) followed by concurrent chemoradiotherapy (CCRT) (46 Gy, 2 Gy/d with oxaliplatin 130 mg/m(2) on days 1 and 21 and S1 30 mg/m(2) twice daily, 5 days per week during radiation therapy) and esophagectomy (arm A), or the same CCRT followed by esophagectomy without ICT (arm B)." | 2.80 | Randomized phase 2 trial of S1 and oxaliplatin-based chemoradiotherapy with or without induction chemotherapy for esophageal cancer. ( Cho, KJ; Jang, G; Jung, HY; Kim, HR; Kim, JH; Kim, JY; Kim, SB; Kim, YH; Lee, GH; Ryu, JS; Song, HY; Yoon, DH, 2015) |
| "Eligible patients had T1b or T2 glottic squamous cell carcinomas." | 2.80 | Critical evaluation of a prospective study of concurrent chemoradiotherapy with S-1 for early glottic carcinoma. ( Fujimoto, Y; Hiramatsu, M; Itoh, J; Itoh, Y; Kawamura, M; Kimura, K; Kubota, S; Naganawa, S; Nakahara, R; Okada, T; Shibata, T, 2015) |
| "Thoracic esophageal cancer patients with clinical stage II/III disease, excluding T4, were eligible." | 2.80 | Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604). ( Boku, N; Fuse, N; Kanato, K; Kato, K; Mizusawa, J; Muro, K; Nihei, K; Ohtsu, A; Sato, A; Tahara, M; Takaishi, H; Yamazaki, K, 2015) |
| " S-1 dosage was started at level 1 (55." | 2.79 | A phase I study of concurrent chemoradiotherapy using oral s-1 for head and neck cancer. ( Fujimoto, Y; Itoh, Y; Kato, S; Naganawa, S; Nakashima, T, 2014) |
| " Pharmacokinetic parameters of S-1 granule did not differ from the capsula formulation." | 2.78 | Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer. ( Doi, K; Fujisaka, Y; Hayashi, H; Kawakami, H; Nakagawa, K; Nishimura, Y; Nishina, S; Okamoto, I; Okamoto, K; Satoh, T; Takeda, M; Tanaka, K; Terao, K; Ueda, S, 2013) |
| " Weekly paclitaxel combined with S-1 is a safe regimen and has a promising efficacy." | 2.77 | [A phase II prospective randomized controlled trial of weekly paclitaxel combined with S-1 or fluorouracil for advanced gastric carcinoma]. ( Ba, Y; Deng, T; Guo, ZQ; Hu, CH; Huang, DZ; Meng, JC; Wan, HP; Wang, ML; Xiong, JP; Xu, N; Yan, Z; Yao, Y; Yu, Z; Yu, ZH; Zhang, Y; Zheng, RS; Zhuang, ZX, 2012) |
| " We investigated the activity and toxicity of S-1 in combination with cisplatin in patients with unresectable non-small cell lung cancer (NSCLC)." | 2.76 | An open-label, multicenter, three-stage, phase II study of s-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer. ( Baggstrom, M; Graham, C; Herbst, R; Jones, D; Saito, K; Sandler, A; Zergebel, C, 2011) |
| "This study was conducted to evaluate the efficacy and safety and to compare dosing schedules of gemcitabine combined with S-1 in chemo-naïve non-small cell lung cancer patients." | 2.75 | Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naïve patients with advanced non-small cell lung cancer. ( Ando, M; Funada, Y; Hata, A; Katakami, N; Kotani, Y; Negoro, S; Satouchi, M; Shimada, T; Urata, Y; Yoshimura, S, 2010) |
| "The survival rate of patients with squamous cell carcinoma of the head and neck was 59." | 2.74 | Outpatient chemotherapy with S-1 for recurrent head and neck cancer. ( Shinden, S; Shiotani, A; Watabe, T; Yamashita, T, 2009) |
| "How best to manage advanced esophageal cancer remains unresolved, especially in palliative care." | 2.73 | Concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer. ( Ahn, JS; Cho, SH; Chung, IJ; Kim, HJ; Kim, YK; Lee, JJ; Lee, SR; Nam, TK; Shim, HJ; Yang, DH, 2008) |
| "Patients with pathologically confirmed squamous cell carcinoma and at least one measurable lesion were enrolled." | 2.73 | Multi-institutional phase II trial of S-1 in patients with oral squamous cell carcinoma. ( Hamakawa, H; Harada, K; Nagahata, S; Nagayama, M; Osaki, T; Ryoke, K; Sato, M; Ueyama, Y; Yoshimura, Y, 2008) |
| "Most cases of head and neck squamous cell carcinoma (HNSCC) are in the advanced stages, resulting in a poor prognosis." | 2.43 | [Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma]. ( Horiuchi, C; Ishitoya, J; Katori, H; Matsuda, H; Mikami, Y; Taguchi, T; Toth, G; Tsukuda, M; Yoshida, T, 2006) |
| "Most head and neck carcinomas are squamous cell carcinomas (HNSCCs)." | 2.43 | [Clinical efficacy of administration with S-1 alone for head and neck carcinoma]. ( Horiuchi, C; Ishitoya, J; Katori, H; Matsuda, H; Mikami, Y; Taguchi, T; Toth, G; Tsukuda, M; Yoshida, T, 2006) |
| "Squamous cell lung cancer is one of the major pathological types in patients with non-small cell lung cancer." | 1.62 | Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report. ( Chen, J; Wang, J; Zou, Y, 2021) |
| "To explore the application of evidence-based nursing intervention in the treatment of advanced squamous cell carcinoma of the lung by erlotinib combined with tegafur, gimeracil, and oteracil potassium (TS-1) and its influence on quality of life (QOL)." | 1.62 | Application of Evidence-Based Nursing Intervention in the Treatment of Advanced Squamous Cell Carcinoma of the Lung by Erlotinib Combined with Tegafur, Gimeracil, and Oteracil Potassium and Its Influence on Quality of Life. ( Fu, F; Huang, X; Liu, S; Wang, H; Wen, J, 2021) |
| "Metaplastic squamous cell carcinoma(MSCC)of the breast is very unusual and is histologically characterized by rapid progression." | 1.51 | [A Case of Metaplastic Squamous Cell Carcinoma of the Breast Successfully Treated with S-1]. ( Ando, S; Kamei, R; Kitamura, Y; Nabeya, M; Sakamoto, K; Tokuhisa, A; Yamamoto, T, 2019) |
| "In our department, patients with oral squamous cell carcinoma(OSCC)received preoperative chemotherapy containing S-1 to prevent the growth and dissemination of tumors during the waiting time before definitive surgery." | 1.51 | [Clinicopathological Evaluation of Preoperative Chemotherapy Containing S-1 as a Treatment for Patients with Oral Squamous Cell Carcinoma during Waiting Time for Surgery]. ( Amino, K; Imai, T; Iwai, S; Kanesaki, T; Katou, I; Matsumiya, Y; Meshii, N; Nakazawa, M; Niki, A; Omae, M; Onishi, T; Ota, Y; Suematsu, M; Sumi, T; Takeshita, A; Ueda, M, 2019) |
| "The involvement of S-1 chemotherapy in ATLL development suggests that a test for HTLV-1 antibody should be performed before treatment and that S-1 should not be administered in HTLV-1 positive patients with head and neck carcinoma." | 1.46 | Adult T-cell leukemia/lymphoma in patients with head and neck cancer after S-1 chemotherapy. ( Kurono, Y; Matushita, K; Nagano, H, 2017) |
| "Patients with early and advanced esophageal cancer and relapsed esophageal cancer after radical surgery were included." | 1.43 | Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer. ( Haga, A; Kiritoshi, T; Nakagawa, K; Ohtomo, K; Okuma, K; Takenaka, R; Yamashita, H, 2016) |
| " Severe adverse events were observed in 22 patients (91." | 1.42 | Feasibility and toxicity of adjuvant chemotherapy using S-1 granules for local advanced squamous cell carcinoma of the head and neck. ( Honda, K; Ishikawa, K; Sato, T; Suzuki, S; Yamazaki, K, 2015) |
| "We report a rare case in which primary squamous cell carcinoma of the nipple skin was successfully treated with S-1 alone." | 1.40 | [A case of squamous cell carcinoma of the nipple skin successfully treated with S-1 alone]. ( Ishikawa, M; Miyoshi, K; Murakami, S; Nakano, R; Ohuchi, K; Sozaki, M; Uchiyama, A; Umeda, S, 2014) |
| "It may be useful for esophageal squamous cell carcinoma (ESCC); however, there are insufficient data." | 1.39 | S-1 monotherapy as second- or third-line chemotherapy for unresectable and recurrent esophageal squamous cell carcinoma. ( Akutsu, Y; Hanaoka, T; Hoshino, I; Kono, T; Matsubara, H; Narushima, K; Qin, W; Semba, Y; Tochigi, T; Uesato, M, 2013) |
| "The hazard ratio for distant metastases in the S-1+ group was 0." | 1.38 | Adjuvant chemotherapy with an oral fluoropyrimidine, S-1, following reduced RADPLAT in advanced laryngeal cancer. ( Endo, K; Kondo, S; Murono, S; Wakisaka, N; Yoshizaki, T, 2012) |
| "The pathological diagnosis revealed squamous cell carcinoma of the left breast(pT3N1M0, Stage III A)." | 1.38 | [A resected case of complete response after treatment with S-1 for recurrent squamous cell carcinoma component of the breast]. ( Arihiro, K; Emi, A; Haruta, R; Kadoya, T; Kajitani, K; Kanno, E; Kataoka, T; Kobayashi, Y; Masumoto, N; Okada, M; Sasada, T; Shigematsu, H, 2012) |
| "Squamous cell carcinoma was elevated to 16 ng/mL." | 1.38 | [A case of a geriatric patient with stage IV anal canal cancer showing complete response to chemoradiation therapy]. ( Hirai, R; Ikeda, E; Kuroda, M; Takagi, S; Tsuji, H; Yamano, T; Yoshitomi, S, 2012) |
| "3 ± 1." | 1.37 | [Clinical analyses of oral squamous cell carcinoma patients showing a complete response to chemotherapy with S-1 alone]. ( Aoki, M; Iwamoto, O; Koga, C; Koga, M; Kusukawa, J; Nakamura, M, 2011) |
| "The patient was diagnosed as having squamous cell carcinoma of the anal cana (l cStage III)." | 1.37 | [A case report of chemoradiotherapy combined with S-1 responding to squamous cell carcinoma of the anal canal]. ( Baba, H; Goseki, N; Kuwabara, H; Nakajima, K; Nakamura, H; Sanada, T; Wakabayashi, M, 2011) |
| " The main adverse events were hematological toxicity, mucositis and dermatitis." | 1.37 | Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer. ( Murai, M; Ohashi, T; Ohnishi, M; Tanahashi, S, 2011) |
| "Primary cutaneous squamous cell carcinoma (SCC) is a malignant tumor that arises from keratinizing cells of the epidermis or its appendages." | 1.36 | Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy. ( Ibusuki, A; Kanekura, T; Kawai, K; Kubo, H; Matsushita, S; Mera, K; Tada, K; Yoshii, N, 2010) |
| " In this study, the response of human OSCC cells to Lentinan alone and in combination with S-1 was examined using nude mouse xenograft models." | 1.36 | Effects of lentinan alone and in combination with fluoropyrimidine anticancer agent on growth of human oral squamous cell carcinoma in vitro and in vivo. ( Harada, K; Itashiki, Y; Takenawa, T; Ueyama, Y, 2010) |
| "Cepharanthine is a biscoclaurine alkaloid extracted from Stephania cepharantha Hayata, which is widely used for the treatment of many acute and chronic diseases, and can exert antitumor effects on several human cancer cells." | 1.35 | Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. ( Ferdous, T; Harada, K; Itashiki, Y; Mano, T; Mori, Y; Takii, M; Ueyama, Y, 2009) |
| "Approximately 50% of oral squamous cell carcinomas (OSCC) exhibit cervical lymph node metastasis." | 1.35 | S-1 mediates the inhibition of lymph node metastasis in oral cancer cells. ( Ando, Y; Hatori, M; Kurihara, Y; Sato, H; Shintani, S; Shirota, T; Tachikawa, T; Takayama, S, 2009) |
| "Thirteen patients with squamous cell carcinoma (SCC) and 3 patients with non-SCC who had recurrent/metastatic disease received S-1 monotherapy as outpatients." | 1.35 | Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer. ( Ishikawa, K; Suzuki, S, 2009) |
| " Regulating the dosage and intervals of S-1 enabled the patients in both cases to survive with cancer as outpatients for 2 years and 2 months after the initial visit (1 year and 10 months from the start of the administration of S-1) in the former case and 3 years from the initial visit (2 years and 1 month from the start of the administration of S-1) in the latter case." | 1.35 | [Two cases of head and neck squamous cell carcinoma in which S-1 administration resulted in long-term sustained QOL]. ( Furuya, A; Kobayashi, S; Monden, T; Mori, T; Ono, T; Sanbe, T; Shimane, T; Suzaki, H, 2009) |
| "Also, bronchoscope and TBLB revealed squamous cell carcinoma." | 1.35 | [A case of multidrug-resistant squamous cell lung carcinoma responding to S-1 plus CPT-11 combination chemotherapy]. ( Iino, K; Morita, M; Sasaki, H; Tomita, K; Toyoshima, H, 2008) |
| "A resected case of squamous cell carcinoma associated with ductal carcinoma in the hemilateral breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases is reported with some discussion." | 1.34 | [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases]. ( Akagawa, T; Fujioka, S; Hara, T; Hiramatsu, K; Hirata, A; Ito, T; Kato, K; Kutsuna, Y; Machiki, Y; Matsuba, H; Miyata, T, 2007) |
| "He was diagnosed as having esophageal cancer of stage IVa (T2N4M0) in October, 2002, and he received chemoradiotherapy (nedaplatin (CDGP)/5-fluorouracil (5-FU) total 6 course+60 Gy)." | 1.34 | [Recurrent esophageal cancer with complete response to TS-1 chemotherapy]. ( Chinen, T; Fujita, J; Hirata, T; Hokama, A; Kinjo, F; Kinjo, N; Nakachi, N; Nakamoto, M; Uchima, N; Watanabe, T, 2007) |
| "A 76-year-old patient with oral squamous cell carcinoma was treated by chemotherapy with S-1." | 1.34 | [A case of oral squamous cell carcinoma responding to S-1]. ( Bando, T; Harada, K; Tamatani, T; Yoshida, H, 2007) |
| "In the patients with oral squamous cell carcinoma (OSCC), S-1 was given orally according to a 4-week application followed by 2-week rest regimen (4-week regimen), or a 2-week application followed by a 1-week rest regimen (2-week regimen)." | 1.34 | Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma. ( Ferdous, T; Harada, K; Yoshida, H, 2007) |
| "We report a patient with advanced esophageal cancer who achieved a complete response to combination chemotherapy of TS-1, docetaxel and CDDP." | 1.33 | [Combination chemotherapy of TS-1, docetaxel and CDDP produces a remarkable response in a patient with advanced esophageal cancer]. ( Kitakata, H; Omote, K; Takahashi, Y; Yamashita, K; Yasumoto, K, 2006) |
| "He had also been suffering from interstitial pneumonitis for several years." | 1.33 | [A case of advanced double cancer of the lung and stomach responding to combination chemotherapy of cisplatin and TS-1]. ( Ishida, T; Munakata, K; Munakata, M; Ohtsuka, Y; Saito, J; Sato, S; Sugawara, A; Watanabe, K; Yoshikawa, M, 2006) |
| "Twenty-five patients with oral squamous cell carcinoma (OSCC) received S-1 80 mg/m2/day." | 1.33 | Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1. ( Harada, K; Kawashima, Y; Sato, M; Yoshida, H, 2006) |
| "This chemotherapy made it possible to treat liver and lymph node metastasis in an ambulatory setting." | 1.33 | [A case of recurrent esophageal cancer responding to second-line chemotherapy of TS-1/docetaxel combination]. ( Hashimoto, Y; Hayashidani, Y; Morifuji, M; Murakami, Y; Sudo, A; Sueda, T; Sugiyama, Y; Uemura, K, 2006) |
| "A 70-year-old patient with advanced esophageal cancer with invasion to the aorta was treated by combined chemotherapy of TS-1 and CDDP with radiotherapy." | 1.32 | [Complete response in a case of advanced esophageal cancer treated by combined chemotherapy of TS-1 and CDDP with radiotherapy]. ( Doi, R; Indou, T; Iwase, H; Iyo, T; Kaida, S; Nakarai, K; Okeya, M; Shimada, M, 2004) |
| "Synchronous esophageal and gastric cancer were diagnosed by endoscopy and barium swallow." | 1.32 | [A case of synchronous esophageal and gastric cancer successfully treated by combination TS-1/CDDP therapy with irradiation]. ( Fujiwara, Y; Fukuhara, K; Harada, S; Kaneko, M; Kinoshita, H; Lee, S; Nishizawa, S; Osugi, H; Taguchi, S; Takemura, M; Tanaka, Y, 2004) |
| "A 51-year-old male patient with esophageal cancer and cervical, thoracic and celiac artery lymph node metastases was treated by combination chemotherapy of TS-1 and cisplatin." | 1.32 | [A case of metastatic esophageal cancer responding remarkably to combination chemotherapy of TS-1 and cisplatin]. ( Doi, R; Iwase, H; Kaida, S; Nakarai, K; Okeya, M; Shimada, M; Tsuzuki, T, 2004) |
| "We report a recent case of squamous cell carcinoma originating in the right tonsil, with metastasis to the right superior cervical lymph nodes (T3N2bM0: stage IVA)." | 1.32 | [A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1]. ( Hashimoto, K; Iguchi, H; Nakamura, A; Sunami, K; Takayama, M; Yamane, H, 2003) |
| "We report a case of advanced squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to oral chemotherapy with TS-1." | 1.32 | [An advanced case of squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to chemotherapy with TS-1]. ( Mishima, K; Nakamura, H; Obara, S; Yamamoto, K; Yoshimura, Y, 2004) |
| "Human oral cancer cell lines were used as subcutaneous xenografts in nude mice." | 1.32 | Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells. ( Harada, K; Kawaguchi, S; Onoue, T; Sato, M; Yoshida, H, 2004) |
| "A 66-year-old patient, who had advanced esophageal cancer with lymph node metastasis, was treated by neoadjuvant chemo-radiotherapy, followed by curative surgery." | 1.32 | [A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy]. ( Kabashima, A; Matsusaka, T; Nishizaki, T; Ojima, Y; Sakaguchi, Y; Shimabukuro, R; Tashiro, H; Yamamoto, H; Yamamura, S, 2004) |
| "A 64-year-old male with primary squamous cell carcinoma of the tongue (T3N0M0) was treated with the novel fluoropyrimidine oral anticancer drug TS-1 and selective intra-arterial infusion of CDDP." | 1.32 | [Combination therapy of fluoropyrimidine (TS-1) administration and selective intra-arterial cisplatin infusion for tongue carcinoma--a case report]. ( Takeda, M; Tanaka, N; Yoshioka, H, 2003) |
| "A 75-year-old female with squamous cell carcinoma in the left margin of the tongue (T2N0M0) was referred to our hospital." | 1.32 | [A case report of tongue squamous cell carcinoma showing a complete response to TS-1]. ( Ikeda, H; Inokuchi, T; Irie, A; Mizoguchi, Y; Shibahara, K; Takebe, Y; Yamada, K, 2003) |
| "A 60-year-old man had a recurrence of squamous cell carcinoma at the right side of the tongue base." | 1.31 | [Long-term complete response to treatment with TS-1 in a patient with oropharyngeal squamous cell carcinoma]. ( Fukuda, S; Furuta, Y; Homma, A; Inuyama, Y; Oridate, N; Suzuki, F, 2002) |
| "Thus, gastric cancer was treated by chemotherapy and esophageal cancer by concurrent chemoradiotherapy with chemotherapy used for gastric cancer." | 1.31 | [Complete response in a case of simultaneous esophageal and gastric cancer treated by combined radiotherapy and chemotherapy of TS-1 and CDDP]. ( Hiraiwa, A; Indo, T; Iwase, H; Iyo, T; Kaida, S; Mizuno, T; Nakamura, M; Nakarai, K, 2002) |
| "The patient was a 78-year-old man." | 1.31 | [A case of gastric cancer in the stomach wall used for mediastinal reconstruction after esophagectomy in which surgery was abandoned due to advanced age and complications but TS-1 was useful]. ( Fujiwara, Y; Fukuhara, K; Hashimoto, Y; Kinoshita, H; Lee, S; Nishizawa, S; Osugi, H; Takada, N; Takemura, M; Tanaka, Y; Ueno, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.54) | 18.2507 |
| 2000's | 74 (40.00) | 29.6817 |
| 2010's | 104 (56.22) | 24.3611 |
| 2020's | 6 (3.24) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S | 1 |
| Huang, X | 2 |
| Wen, J | 1 |
| Fu, F | 1 |
| Wang, H | 1 |
| Yamamoto, T | 2 |
| Nabeya, M | 1 |
| Tokuhisa, A | 1 |
| Kamei, R | 1 |
| Sakamoto, K | 1 |
| Kitamura, Y | 1 |
| Ando, S | 1 |
| Tanaka, H | 1 |
| Tabe, C | 1 |
| Okumura, F | 1 |
| Shiratori, T | 1 |
| Ishioka, Y | 1 |
| Itoga, M | 1 |
| Taima, K | 1 |
| Morimoto, T | 1 |
| Kimura, D | 1 |
| Tsushima, T | 2 |
| Tasaka, S | 1 |
| Tanaka, K | 2 |
| Morita, S | 3 |
| Ando, M | 2 |
| Yokoyama, T | 1 |
| Nakamura, A | 3 |
| Yoshioka, H | 3 |
| Ishiguro, T | 1 |
| Miura, S | 1 |
| Toyozawa, R | 1 |
| Oguri, T | 1 |
| Daga, H | 1 |
| Ko, R | 1 |
| Bessho, A | 1 |
| Tachihara, M | 1 |
| Iwamoto, Y | 1 |
| Hirano, K | 1 |
| Nakanishi, Y | 2 |
| Nakagawa, K | 7 |
| Yamamoto, N | 6 |
| Okamoto, I | 2 |
| Kanda, M | 1 |
| Koike, M | 1 |
| Iwata, N | 1 |
| Shimizu, D | 1 |
| Tanaka, C | 1 |
| Hattori, N | 1 |
| Hayashi, M | 1 |
| Yamada, S | 1 |
| Omae, K | 1 |
| Nakayama, G | 1 |
| Kodera, Y | 1 |
| Takahashi, D | 1 |
| Demizu, Y | 1 |
| Park, SC | 1 |
| Matsuo, Y | 1 |
| Sulaiman, NS | 1 |
| Terashima, K | 2 |
| Tokumaru, S | 1 |
| Akashi, M | 1 |
| Okimoto, T | 1 |
| Chen, J | 2 |
| Wang, J | 3 |
| Zou, Y | 1 |
| Fang, M | 1 |
| Song, T | 1 |
| Liang, X | 1 |
| Lv, S | 1 |
| Li, J | 1 |
| Xu, H | 1 |
| Luo, L | 1 |
| Jia, Y | 2 |
| Song, GM | 1 |
| Tian, X | 1 |
| Liu, XL | 1 |
| Chen, H | 1 |
| Zhou, JG | 1 |
| Bian, W | 1 |
| Chen, WQ | 1 |
| Takakura, H | 1 |
| Domae, S | 1 |
| Ono, T | 2 |
| Sasaki, A | 1 |
| Kitani, Y | 2 |
| Kubota, A | 4 |
| Furukawa, M | 3 |
| Hori, Y | 1 |
| Nakayama, Y | 1 |
| Nonaka, T | 2 |
| Mizoguchi, N | 1 |
| Hatakeyama, H | 1 |
| Oridate, N | 3 |
| Hata, Y | 1 |
| Kiribayashi, T | 1 |
| Kishi, K | 2 |
| Nagashima, M | 1 |
| Nakayama, T | 1 |
| Ikeda, S | 1 |
| Kadokura, M | 1 |
| Ozeki, Y | 1 |
| Otsuka, H | 1 |
| Murakami, Y | 3 |
| Takagi, K | 1 |
| Iyoda, A | 1 |
| Nokihara, H | 3 |
| Lu, S | 1 |
| Mok, TSK | 1 |
| Shi, YK | 1 |
| Zhang, L | 1 |
| Soo, RA | 1 |
| Yang, JC | 1 |
| Sugawara, S | 2 |
| Nishio, M | 3 |
| Takahashi, T | 3 |
| Goto, K | 1 |
| Chang, J | 1 |
| Maemondo, M | 1 |
| Ichinose, Y | 4 |
| Cheng, Y | 2 |
| Lim, WT | 1 |
| Tamura, T | 2 |
| Wen, Y | 1 |
| Zhao, Z | 1 |
| Miao, J | 1 |
| Yang, Q | 1 |
| Gui, Y | 1 |
| Sun, M | 1 |
| Tian, H | 1 |
| Jia, Q | 1 |
| Liao, D | 1 |
| Yang, C | 2 |
| Du, X | 1 |
| Ojima, T | 1 |
| Nakamura, M | 4 |
| Nakamori, M | 1 |
| Katsuda, M | 1 |
| Hayata, K | 1 |
| Maruoka, S | 1 |
| Shimokawa, T | 1 |
| Yamaue, H | 1 |
| Kimura, K | 2 |
| Itoh, Y | 3 |
| Okada, T | 2 |
| Kubota, S | 2 |
| Kawamura, M | 2 |
| Nakahara, R | 2 |
| Oie, Y | 1 |
| Kozai, Y | 1 |
| Takase, Y | 1 |
| Tsuzuki, H | 1 |
| Nishio, N | 1 |
| Hiramatsu, M | 2 |
| Fujimoto, Y | 3 |
| Mizutani, T | 1 |
| Hirakawa, A | 1 |
| Naganawa, S | 3 |
| Hanibuchi, M | 1 |
| Kakiuchi, S | 1 |
| Atagi, S | 1 |
| Ogushi, F | 1 |
| Shimizu, E | 1 |
| Haku, T | 1 |
| Toyoda, Y | 1 |
| Azuma, M | 1 |
| Kondo, M | 1 |
| Kawano, H | 1 |
| Otsuka, K | 1 |
| Sakaguchi, S | 1 |
| Goto, H | 1 |
| Nishioka, Y | 1 |
| Soda, H | 1 |
| Ogawara, D | 1 |
| Fukuda, Y | 3 |
| Tomono, H | 1 |
| Okuno, D | 1 |
| Koga, S | 1 |
| Taniguchi, H | 2 |
| Yoshida, M | 2 |
| Harada, T | 2 |
| Umemura, A | 1 |
| Yamaguchi, H | 1 |
| Mukae, H | 1 |
| Yokoi, T | 1 |
| Minami, S | 1 |
| Shiroyama, T | 1 |
| Koba, T | 1 |
| Torii, Y | 1 |
| Sugimoto, H | 1 |
| Niki, M | 1 |
| Mori, M | 1 |
| Morimura, O | 1 |
| Hirashima, T | 1 |
| Komuta, K | 1 |
| Kijima, T | 2 |
| Akiyama, N | 1 |
| Karayama, M | 2 |
| Inui, N | 2 |
| Yasui, H | 3 |
| Hozumi, H | 1 |
| Suzuki, Y | 1 |
| Furuhashi, K | 1 |
| Fujisawa, T | 2 |
| Enomoto, N | 2 |
| Nakamura, Y | 4 |
| Inami, N | 1 |
| Matsuura, S | 1 |
| Kaida, Y | 1 |
| Uto, T | 1 |
| Matsui, T | 1 |
| Asada, K | 2 |
| Matsuda, H | 7 |
| Fujii, M | 10 |
| Toyoshima, M | 2 |
| Suda, T | 2 |
| Li, C | 1 |
| Wang, X | 2 |
| Han, C | 1 |
| Wang, P | 1 |
| Pang, Q | 1 |
| Sun, X | 1 |
| Wang, L | 1 |
| Zhang, W | 1 |
| Lin, Y | 1 |
| Ge, X | 1 |
| Zhou, Z | 1 |
| Ni, W | 1 |
| Chang, X | 1 |
| Liang, J | 1 |
| Deng, L | 1 |
| Wang, W | 1 |
| Zhao, Y | 2 |
| Xiao, Z | 1 |
| Matsumiya, Y | 1 |
| Imai, T | 1 |
| Takeshita, A | 1 |
| Meshii, N | 1 |
| Katou, I | 1 |
| Iwai, S | 2 |
| Suematsu, M | 1 |
| Omae, M | 1 |
| Kanesaki, T | 1 |
| Ota, Y | 1 |
| Onishi, T | 1 |
| Amino, K | 1 |
| Sumi, T | 2 |
| Niki, A | 1 |
| Ueda, M | 1 |
| Nakazawa, M | 4 |
| Seki-Soda, M | 1 |
| Sano, T | 1 |
| Koshi, H | 1 |
| Yokoo, S | 2 |
| Oyama, T | 2 |
| Bae, WK | 1 |
| Hwang, JE | 1 |
| Shim, HJ | 2 |
| Cho, SH | 2 |
| Lee, KH | 1 |
| Han, HS | 1 |
| Song, EK | 1 |
| Yun, HJ | 1 |
| Cho, IS | 1 |
| Lee, JK | 1 |
| Lim, SC | 1 |
| Chung, WK | 1 |
| Chung, IJ | 2 |
| Harada, H | 3 |
| Murakami, H | 1 |
| Ohyanagi, F | 1 |
| Kozuka, T | 1 |
| Ishikura, S | 1 |
| Naito, T | 1 |
| Kaira, K | 2 |
| Horiike, A | 1 |
| Nishimura, T | 2 |
| Kobayashi, R | 1 |
| Yamashita, H | 2 |
| Okuma, K | 2 |
| Shiraishi, K | 1 |
| Ohtomo, K | 2 |
| Akutsu, Y | 1 |
| Kono, T | 1 |
| Uesato, M | 1 |
| Hoshino, I | 1 |
| Narushima, K | 1 |
| Hanaoka, T | 1 |
| Tochigi, T | 1 |
| Semba, Y | 1 |
| Qin, W | 1 |
| Matsubara, H | 1 |
| Ferdous, T | 3 |
| Harada, K | 11 |
| Kin, T | 1 |
| Ueyama, Y | 4 |
| Maeda, M | 1 |
| Yamashita, T | 3 |
| Matsunobu, T | 1 |
| Araki, K | 1 |
| Tomifuji, M | 1 |
| Shiotani, A | 2 |
| Hayashi, H | 2 |
| Ueda, S | 1 |
| Okamoto, K | 2 |
| Kawakami, H | 1 |
| Nishina, S | 1 |
| Takeda, M | 2 |
| Fujisaka, Y | 1 |
| Satoh, T | 2 |
| Terao, K | 1 |
| Nishimura, Y | 1 |
| Doi, K | 1 |
| Kato, S | 1 |
| Nakashima, T | 4 |
| Yaguchi, Y | 1 |
| Kawaguchi, M | 1 |
| Murata, I | 1 |
| Okamura, K | 1 |
| Katagiri, Y | 1 |
| Suzuki, T | 2 |
| Sato, D | 1 |
| Kogashiwa, Y | 3 |
| Tsukahara, K | 2 |
| Yamauchi, K | 2 |
| Kohno, N | 6 |
| Toyoda, M | 1 |
| Ohshima, Y | 1 |
| Ishioka, NS | 1 |
| Shino, M | 1 |
| Sakakura, K | 1 |
| Takayasu, Y | 1 |
| Takahashi, K | 1 |
| Tominaga, H | 1 |
| Oriuchi, N | 1 |
| Nagamori, S | 1 |
| Kanai, Y | 1 |
| Chikamatsu, K | 1 |
| Teramoto, Y | 1 |
| Yamada, K | 2 |
| Yamamoto, A | 1 |
| Matsumoto, H | 1 |
| Kubota, H | 2 |
| Higashida, M | 1 |
| Yoden, E | 1 |
| Hiratsuka, J | 1 |
| Haruma, K | 1 |
| Hirai, T | 3 |
| Murakami, S | 1 |
| Umeda, S | 1 |
| Sozaki, M | 1 |
| Miyoshi, K | 1 |
| Ishikawa, M | 1 |
| Uchiyama, A | 1 |
| Ohuchi, K | 1 |
| Nakano, R | 1 |
| Taguchi, T | 7 |
| Takahashi, M | 2 |
| Nishimura, G | 3 |
| Shiono, O | 2 |
| Komatsu, M | 2 |
| Sano, D | 1 |
| Sakuma, Y | 2 |
| Tanigaki, Y | 2 |
| Taguri, M | 1 |
| Hata, M | 1 |
| Hoshikawa, H | 1 |
| Kishino, T | 1 |
| Mori, T | 2 |
| Indo, K | 1 |
| Inamoto, R | 1 |
| Akiyama, K | 1 |
| Miyashita, T | 1 |
| Mori, N | 1 |
| Yao, L | 1 |
| Xu, S | 1 |
| Xu, J | 1 |
| Sun, D | 1 |
| Hasegawa, Y | 5 |
| Takemura, H | 3 |
| Terada, T | 1 |
| Nagahara, K | 1 |
| Nakatani, H | 1 |
| Yoshino, K | 1 |
| Higaki, Y | 2 |
| Iwae, S | 2 |
| Beppu, T | 1 |
| Hanamure, Y | 1 |
| Tomita, K | 3 |
| Kawabata, K | 1 |
| Fukushima, M | 1 |
| Teramukai, S | 1 |
| Yoon, DH | 2 |
| Jang, G | 1 |
| Kim, JH | 3 |
| Kim, YH | 1 |
| Kim, JY | 1 |
| Kim, HR | 3 |
| Jung, HY | 1 |
| Lee, GH | 1 |
| Song, HY | 1 |
| Cho, KJ | 2 |
| Ryu, JS | 1 |
| Kim, SB | 2 |
| Nakashima, S | 1 |
| Kiuchi, J | 1 |
| Konishi, T | 1 |
| Umehara, S | 1 |
| Fukuda, K | 1 |
| Fujiyama, J | 1 |
| Masuyama, M | 1 |
| Tahara, M | 5 |
| Kiyota, N | 2 |
| Mizusawa, J | 2 |
| Nakamura, K | 6 |
| Hayashi, R | 3 |
| Akimoto, T | 2 |
| Monden, N | 1 |
| Matsuura, K | 2 |
| Fujii, H | 1 |
| Onozawa, Y | 3 |
| Homma, A | 3 |
| Fukuda, H | 3 |
| Itoh, J | 1 |
| Shibata, T | 2 |
| Kubota, K | 3 |
| Sakai, H | 3 |
| Katakami, N | 2 |
| Inoue, A | 1 |
| Okamoto, H | 2 |
| Isobe, H | 1 |
| Kunitoh, H | 2 |
| Takiguchi, Y | 2 |
| Kobayashi, K | 1 |
| Ohmatsu, H | 1 |
| Minato, K | 2 |
| Fukuda, M | 2 |
| Yokoyama, A | 1 |
| Takeuchi, M | 1 |
| Michimae, H | 1 |
| Gemma, A | 1 |
| Kudoh, S | 1 |
| Suzuki, S | 4 |
| Honda, K | 1 |
| Sato, T | 3 |
| Yamazaki, K | 3 |
| Ishikawa, K | 3 |
| Negishi, A | 1 |
| Ogawa, M | 1 |
| Kosugi, K | 1 |
| Takayama, Y | 1 |
| Gomi, A | 1 |
| Miyazaki, H | 1 |
| Hirai, M | 1 |
| Orita, Y | 1 |
| Takao, S | 1 |
| Tachibana, T | 1 |
| Marunaka, H | 1 |
| Makihara, S | 1 |
| Miki, K | 1 |
| Noyama, Y | 1 |
| Fuji, S | 1 |
| Torigoe, A | 1 |
| Sato, Y | 1 |
| Nishizaki, K | 1 |
| Ikeda, A | 1 |
| Okuno, T | 1 |
| Miki, I | 1 |
| Yokozaki, H | 1 |
| Kutsumi, H | 1 |
| Azuma, T | 1 |
| Fuse, N | 1 |
| Sato, A | 1 |
| Nihei, K | 1 |
| Kanato, K | 1 |
| Kato, K | 2 |
| Muro, K | 1 |
| Takaishi, H | 1 |
| Boku, N | 3 |
| Ohtsu, A | 2 |
| Tagawa, T | 1 |
| Iwata, T | 1 |
| Nakajima, T | 2 |
| Suzuki, H | 1 |
| Yoshida, S | 1 |
| Yoshino, I | 1 |
| Haga, A | 1 |
| Takenaka, R | 1 |
| Kiritoshi, T | 1 |
| Lee, CG | 1 |
| Choi, EC | 2 |
| Koh, YW | 2 |
| Cho, BC | 2 |
| Yao, B | 1 |
| Tan, B | 1 |
| Wang, C | 1 |
| Song, Q | 1 |
| Guan, S | 1 |
| Ma, Y | 1 |
| Sun, Y | 1 |
| Wakisaka, N | 2 |
| Hirai, N | 1 |
| Kondo, S | 2 |
| Aga, M | 1 |
| Tsuji, A | 1 |
| Endo, K | 2 |
| Murono, S | 2 |
| Yoshizaki, T | 2 |
| Tanaka, Y | 4 |
| Yoshida, K | 2 |
| Tanahashi, T | 1 |
| Okumura, N | 1 |
| Matsuhashi, N | 1 |
| Yamaguchi, K | 2 |
| Wang, T | 1 |
| Zhang, SF | 1 |
| Qiu, MQ | 1 |
| Li, QL | 1 |
| Yasumatsu, R | 1 |
| Sato, M | 6 |
| Nakano, T | 1 |
| Kogo, R | 1 |
| Hashimoto, K | 2 |
| Sawatsubashi, M | 1 |
| Nakagawa, T | 1 |
| Yokota, T | 2 |
| Iida, Y | 1 |
| Ogawa, H | 1 |
| Kamijo, T | 1 |
| Todaka, A | 2 |
| Hamauchi, S | 2 |
| Onoe, T | 1 |
| Nakagawa, M | 1 |
| Yurikusa, T | 1 |
| Tanuma, A | 1 |
| Yamashita, A | 1 |
| Onitsuka, T | 1 |
| Kuroishi, S | 1 |
| Yokomura, K | 1 |
| Koshimizu, N | 1 |
| Imokawa, S | 1 |
| Masuda, M | 3 |
| Yamada, T | 2 |
| Watanabe, H | 1 |
| Nagano, H | 1 |
| Kurono, Y | 1 |
| Matushita, K | 1 |
| Kano, K | 1 |
| Maezawa, Y | 1 |
| Segami, K | 1 |
| Ikeda, K | 1 |
| Hayashi, T | 1 |
| Ohshima, T | 1 |
| Yukawa, N | 1 |
| Rino, Y | 1 |
| Ogata, T | 1 |
| Cho, H | 1 |
| Yoshikawa, T | 1 |
| Wang, HY | 1 |
| Yao, ZH | 1 |
| Tang, H | 1 |
| Jin, SL | 1 |
| Zhou, WP | 1 |
| Yao, SN | 1 |
| Yang, SJ | 1 |
| Liu, YY | 1 |
| Luo, SX | 1 |
| Nishiguchi, R | 1 |
| Kim, DH | 1 |
| Honda, M | 1 |
| Sakamoto, T | 1 |
| Lee, SR | 1 |
| Ahn, JS | 1 |
| Yang, DH | 1 |
| Kim, YK | 1 |
| Nam, TK | 1 |
| Lee, JJ | 1 |
| Kim, HJ | 1 |
| Hoshino, S | 1 |
| Sugano, T | 1 |
| Kitamura, T | 1 |
| Aragane, K | 1 |
| Tsukuda, M | 11 |
| Ishitoya, J | 5 |
| Mikami, Y | 3 |
| Horiuchi, C | 4 |
| Satake, K | 2 |
| Kawano, T | 1 |
| Kawakami, M | 1 |
| Watanabe, M | 2 |
| Yamashita, Y | 3 |
| Shinden, S | 1 |
| Watabe, T | 1 |
| Itashiki, Y | 2 |
| Takii, M | 1 |
| Mano, T | 1 |
| Mori, Y | 1 |
| Koga, M | 3 |
| Anegawa, E | 2 |
| Yoh, J | 1 |
| Tsuyama, H | 1 |
| Sakaino, H | 1 |
| Iwamoto, O | 3 |
| Koga, C | 3 |
| Kusukawa, J | 3 |
| Shimane, T | 1 |
| Monden, T | 1 |
| Furuya, A | 1 |
| Kobayashi, S | 2 |
| Sanbe, T | 3 |
| Suzaki, H | 2 |
| Nomura, T | 2 |
| Murakami, R | 2 |
| Toya, R | 1 |
| Teshima, K | 2 |
| Nakahara, A | 1 |
| Hiraki, A | 3 |
| Nakayama, H | 3 |
| Yoshitake, Y | 1 |
| Ota, K | 1 |
| Obayashi, T | 1 |
| Oya, N | 1 |
| Shinohara, M | 3 |
| Sato, H | 1 |
| Hatori, M | 1 |
| Ando, Y | 1 |
| Kurihara, Y | 1 |
| Takayama, S | 1 |
| Shirota, T | 1 |
| Tachikawa, T | 1 |
| Shintani, S | 5 |
| Abo, H | 1 |
| Niho, T | 1 |
| Kuga, Y | 1 |
| Tanaka, T | 1 |
| Arita, M | 1 |
| Usui, Y | 1 |
| Okanobu, H | 1 |
| Numata, Y | 1 |
| Miwata, T | 1 |
| Yoshimi, S | 1 |
| Murakami, E | 1 |
| Moriya, T | 1 |
| Ohya, T | 1 |
| Nishida, T | 1 |
| Nishijima, W | 1 |
| Yamane, H | 4 |
| Tomita, T | 1 |
| Sugiura, Y | 1 |
| Takeuchi, K | 1 |
| Kakizaki, T | 1 |
| Kaseda, S | 1 |
| Satouchi, M | 1 |
| Kotani, Y | 1 |
| Shimada, T | 1 |
| Urata, Y | 1 |
| Yoshimura, S | 1 |
| Funada, Y | 1 |
| Hata, A | 1 |
| Negoro, S | 1 |
| Takeda, K | 1 |
| Saijo, N | 1 |
| Ariyoshi, Y | 1 |
| Fukuoka, M | 1 |
| Omura, K | 2 |
| Nakayama, M | 1 |
| Hayakawa, K | 1 |
| Okamoto, M | 1 |
| Niibe, Y | 1 |
| Ishiyama, H | 1 |
| Kotani, S | 1 |
| Nonoshita, T | 1 |
| Shioyama, Y | 3 |
| Ohga, S | 1 |
| Yoshitake, T | 1 |
| Ohnishi, K | 2 |
| Asai, K | 1 |
| Honda, H | 2 |
| Matsushita, S | 1 |
| Kawai, K | 1 |
| Tada, K | 1 |
| Mera, K | 1 |
| Kubo, H | 1 |
| Ibusuki, A | 1 |
| Yoshii, N | 1 |
| Kanekura, T | 1 |
| Segawa, Y | 1 |
| Kiura, K | 1 |
| Hotta, K | 1 |
| Takigawa, N | 2 |
| Tabata, M | 1 |
| Matsuo, K | 1 |
| Kawai, H | 1 |
| Aoe, K | 1 |
| Maeda, T | 1 |
| Ueoka, H | 1 |
| Tanimoto, M | 1 |
| Takenawa, T | 1 |
| Cho, Y | 1 |
| Kim, SY | 1 |
| Nam, SY | 1 |
| Choi, SH | 1 |
| Roh, JL | 1 |
| Lee, SW | 1 |
| Song, SY | 1 |
| Lee, JH | 1 |
| Kim, JS | 1 |
| Shinoto, M | 1 |
| Sasaki, T | 1 |
| Ohura, H | 1 |
| Toh, Y | 1 |
| Yamaguchi, T | 1 |
| Atsumi, K | 1 |
| Hirata, H | 1 |
| Morimoto, M | 2 |
| Yui, T | 1 |
| Nagafuji, H | 2 |
| Matsuda, T | 1 |
| Tsubosaka, T | 1 |
| Karaho, T | 1 |
| Maruyama, T | 2 |
| Seto, T | 1 |
| Nogami, N | 1 |
| Shinkai, T | 1 |
| Seki, N | 1 |
| Eguchi, K | 1 |
| Nishikawa, M | 1 |
| Watanabe, K | 2 |
| Ohashi, T | 1 |
| Ohnishi, M | 1 |
| Tanahashi, S | 1 |
| Murai, M | 1 |
| Minami, H | 1 |
| Kawashima, M | 1 |
| Kawada, K | 1 |
| Mukai, H | 1 |
| Sakuraba, M | 1 |
| Ogino, T | 1 |
| Koizumi, T | 1 |
| Agatsuma, T | 1 |
| Komatsu, Y | 1 |
| Kubo, K | 1 |
| Govindan, R | 1 |
| Morgensztern, D | 1 |
| Kommor, MD | 1 |
| Herbst, RS | 1 |
| Schaefer, P | 1 |
| Gandhi, J | 1 |
| Saito, K | 2 |
| Zergebel, C | 2 |
| Schiller, J | 1 |
| Umemura, S | 1 |
| Yano, T | 1 |
| Hoshika, T | 1 |
| Shiote, Y | 1 |
| Suwaki, T | 1 |
| Shirakawa, A | 1 |
| Kamei, H | 1 |
| Kusumoto, M | 1 |
| Toyoda, S | 1 |
| Ishikawa, N | 1 |
| Matsumoto, T | 1 |
| Kusumoto, C | 1 |
| Doi, F | 1 |
| Takashima, A | 1 |
| Shimada, Y | 1 |
| Hamaguchi, T | 1 |
| Ito, Y | 1 |
| Nakano, A | 1 |
| Moriya, Y | 1 |
| Nagai, H | 2 |
| Takamaru, N | 1 |
| Ohe, G | 1 |
| Uchida, D | 2 |
| Tamatani, T | 2 |
| Fujisawa, K | 1 |
| Iwamoto, S | 1 |
| Miyamoto, Y | 2 |
| Furusaka, T | 1 |
| Tanaka, A | 1 |
| Ikeda, M | 1 |
| Sandler, A | 1 |
| Graham, C | 1 |
| Baggstrom, M | 1 |
| Herbst, R | 1 |
| Jones, D | 1 |
| Kawaguchi, K | 1 |
| Sato, K | 1 |
| Yamada, H | 1 |
| Horie, A | 1 |
| Iketani, S | 1 |
| Kanai, I | 1 |
| Nakatani, Y | 1 |
| Hamada, Y | 1 |
| Asahina, H | 1 |
| Sekine, I | 1 |
| Horinouchi, H | 1 |
| Machida, N | 1 |
| Fukutomi, A | 1 |
| Aoki, M | 2 |
| Osada, S | 1 |
| Hata, T | 2 |
| Ohara, N | 1 |
| Masuike, Y | 1 |
| Fujino, S | 1 |
| Yanagawa, T | 1 |
| Kitahara, T | 1 |
| Oshima, K | 1 |
| Nagai, K | 1 |
| Noda, T | 1 |
| Miyake, M | 1 |
| Kawanishi, K | 1 |
| Fujita, J | 2 |
| Iwazawa, T | 1 |
| Akagi, K | 1 |
| Dono, K | 1 |
| Kitada, M | 1 |
| Baba, H | 2 |
| Kuwabara, H | 1 |
| Wakabayashi, M | 1 |
| Nakamura, H | 2 |
| Sanada, T | 1 |
| Nakajima, K | 1 |
| Goseki, N | 1 |
| Uemura, K | 2 |
| Sudo, T | 1 |
| Hashimoto, Y | 3 |
| Nakashima, A | 1 |
| Kondo, N | 1 |
| Nakagawa, N | 1 |
| Sueda, T | 2 |
| Terai, H | 1 |
| Soejima, K | 1 |
| Naoki, K | 1 |
| Ikemura, S | 1 |
| Ogura-Tomomatsu, H | 1 |
| Asano, K | 1 |
| Betsuyaku, T | 1 |
| Yoshida, R | 1 |
| Nakaguchi, Y | 1 |
| Tsujita, N | 1 |
| Tomitaka, E | 1 |
| Furusawa, M | 1 |
| Kim, HS | 2 |
| Kim, GM | 1 |
| Kim, SH | 1 |
| Hong, YK | 1 |
| Sung, JH | 1 |
| Kim, SM | 1 |
| Kobayashi, Y | 1 |
| Kadoya, T | 1 |
| Kanno, E | 1 |
| Sasada, T | 1 |
| Kajitani, K | 1 |
| Emi, A | 1 |
| Shigematsu, H | 1 |
| Masumoto, N | 1 |
| Haruta, R | 1 |
| Kataoka, T | 1 |
| Arihiro, K | 1 |
| Okada, M | 1 |
| Yamamoto, Y | 2 |
| Nakai, N | 1 |
| Wakabayashi, Y | 1 |
| Okuzawa, Y | 1 |
| Asai, J | 1 |
| Takenaka, H | 1 |
| Katoh, N | 1 |
| Kuroda, M | 1 |
| Hirai, R | 1 |
| Ikeda, E | 1 |
| Tsuji, H | 2 |
| Takagi, S | 1 |
| Yamano, T | 1 |
| Yoshitomi, S | 1 |
| Huang, DZ | 1 |
| Xiong, JP | 1 |
| Xu, N | 1 |
| Yan, Z | 1 |
| Zhuang, ZX | 1 |
| Yu, Z | 1 |
| Wan, HP | 1 |
| Zhang, Y | 1 |
| Deng, T | 1 |
| Zheng, RS | 1 |
| Guo, ZQ | 1 |
| Hu, CH | 1 |
| Wang, ML | 1 |
| Yu, ZH | 1 |
| Yao, Y | 1 |
| Meng, JC | 1 |
| Ba, Y | 1 |
| Nakata, K | 1 |
| Sakata, K | 1 |
| Someya, M | 1 |
| Miura, K | 1 |
| Hayashi, J | 1 |
| Hori, M | 1 |
| Takagi, M | 1 |
| Himi, T | 1 |
| Kondo, A | 1 |
| Hareyama, M | 1 |
| Tomioka, H | 1 |
| Yoshihama, Y | 1 |
| Suzuki, F | 1 |
| Furuta, Y | 1 |
| Inuyama, Y | 3 |
| Fukuda, S | 1 |
| Iguchi, H | 2 |
| Sunami, K | 1 |
| Takayama, M | 1 |
| Tanaka, N | 1 |
| Ikeda, H | 1 |
| Takebe, Y | 1 |
| Irie, A | 1 |
| Mizoguchi, Y | 1 |
| Shibahara, K | 1 |
| Inokuchi, T | 1 |
| Nakashiro, K | 2 |
| Yano, J | 1 |
| Shinohara, Y | 1 |
| Terakado, N | 1 |
| Hamakawa, H | 4 |
| Wakabayashi, K | 1 |
| Hayashi, S | 1 |
| Masuda, H | 1 |
| Karube, H | 1 |
| Ookame, H | 1 |
| Aoki, H | 1 |
| Sakamoto, N | 1 |
| Takayama, T | 2 |
| Hino, S | 2 |
| Hara, S | 1 |
| Nakarai, K | 4 |
| Iwase, H | 4 |
| Shimada, M | 3 |
| Iyo, T | 2 |
| Kaida, S | 4 |
| Indou, T | 1 |
| Doi, R | 3 |
| Okeya, M | 3 |
| Takemura, M | 2 |
| Osugi, H | 2 |
| Lee, S | 2 |
| Taguchi, S | 1 |
| Kaneko, M | 1 |
| Fukuhara, K | 2 |
| Fujiwara, Y | 2 |
| Nishizawa, S | 2 |
| Kinoshita, H | 2 |
| Harada, S | 1 |
| Kajikawa, H | 1 |
| Nario, K | 1 |
| Miyahara, H | 1 |
| Yamamoto, K | 1 |
| Obara, S | 1 |
| Mishima, K | 1 |
| Yoshimura, Y | 2 |
| Tsuzuki, T | 1 |
| Kawaguchi, S | 1 |
| Onoue, T | 1 |
| Yoshida, H | 6 |
| Indo, T | 2 |
| Tuzuki, T | 1 |
| Kato, E | 1 |
| Kusuki, M | 1 |
| Nishiura, H | 1 |
| Kanazawa, A | 1 |
| Yoshimori, K | 1 |
| Nakai, Y | 1 |
| Sugiura, T | 1 |
| Kawahara, M | 1 |
| Niitani, H | 1 |
| Sakaguchi, Y | 1 |
| Kabashima, A | 1 |
| Yamamoto, H | 1 |
| Shimabukuro, R | 1 |
| Ojima, Y | 1 |
| Yamamura, S | 1 |
| Nishizaki, T | 1 |
| Tashiro, H | 1 |
| Matsusaka, T | 1 |
| Ohnishi, T | 2 |
| Chisoku, H | 2 |
| Katagiri, W | 1 |
| Doi, T | 1 |
| Takase, T | 1 |
| Yui, S | 2 |
| Miwa, Y | 1 |
| Kishino, M | 2 |
| Yura, Y | 2 |
| Kuratomi, Y | 1 |
| Hirakawa, N | 1 |
| Umezaki, T | 1 |
| Komune, S | 1 |
| Kida, A | 4 |
| Kono, N | 2 |
| Yoshihara, T | 2 |
| Sugita, M | 2 |
| Katsuno, M | 1 |
| Asano, R | 1 |
| Tachibana, S | 1 |
| Iida, M | 1 |
| Kadokura, Y | 1 |
| Ohmae, M | 1 |
| Nakanome, A | 1 |
| Shiga, K | 1 |
| Sagai, S | 1 |
| Ogawa, T | 1 |
| Kobayashi, T | 1 |
| Tsunezuka, Y | 1 |
| Oda, M | 1 |
| Moriyama, H | 1 |
| Kawashima, Y | 3 |
| Sugiyama, Y | 1 |
| Morifuji, M | 1 |
| Hayashidani, Y | 1 |
| Sudo, A | 1 |
| Yasumoto, K | 1 |
| Kitakata, H | 1 |
| Yamashita, K | 1 |
| Omote, K | 1 |
| Takahashi, Y | 1 |
| Sugawara, A | 1 |
| Munakata, K | 1 |
| Ishida, T | 1 |
| Sato, S | 1 |
| Yoshikawa, M | 1 |
| Saito, J | 1 |
| Ohtsuka, Y | 1 |
| Munakata, M | 1 |
| Katori, H | 2 |
| Yoshida, T | 2 |
| Toth, G | 2 |
| Watanabe, A | 1 |
| Taniguchi, M | 1 |
| Tsujie, H | 1 |
| Nagata, M | 1 |
| Inoue, T | 1 |
| Minami, T | 1 |
| Iwai, H | 1 |
| Ohnishi, S | 1 |
| Yukawa, H | 1 |
| Ogura, M | 1 |
| Nagata, K | 1 |
| Osaki, T | 2 |
| Takimoto, T | 1 |
| Inoue, M | 1 |
| Okumura, M | 1 |
| Niju, T | 1 |
| Kumagai, T | 1 |
| Tachibana, I | 1 |
| Kawase, I | 1 |
| Yasumura, T | 1 |
| Kaji, S | 1 |
| Yagawa, A | 1 |
| Ozawa, T | 1 |
| Watanabe, T | 1 |
| Chinen, T | 1 |
| Nakachi, N | 1 |
| Nakamoto, M | 1 |
| Uchima, N | 1 |
| Hirata, T | 1 |
| Hokama, A | 1 |
| Kinjo, N | 1 |
| Kinjo, F | 1 |
| Hiramatsu, K | 1 |
| Hirata, A | 1 |
| Matsuba, H | 1 |
| Hara, T | 1 |
| Ito, T | 1 |
| Miyata, T | 1 |
| Akagawa, T | 1 |
| Kutsuna, Y | 1 |
| Machiki, Y | 1 |
| Fujioka, S | 1 |
| Tezuka, M | 1 |
| Satoh, A | 1 |
| Kaneta, H | 1 |
| Kato, T | 1 |
| Notani, K | 1 |
| Kitagawa, Y | 1 |
| Teruya, T | 1 |
| Yonamine, T | 1 |
| Gabe, A | 1 |
| Kawasaki, H | 1 |
| Kawabata, T | 1 |
| Ohta, M | 1 |
| Kuniyoshi, M | 1 |
| Bando, T | 1 |
| Ishibashi, M | 1 |
| Masuda, N | 1 |
| Noguchi, K | 1 |
| Moridera, K | 1 |
| Nishimura, N | 1 |
| Nishioji, K | 1 |
| Urade, M | 1 |
| Kogo, M | 1 |
| Nagayama, M | 1 |
| Nagahata, S | 1 |
| Ryoke, K | 1 |
| Choi, YJ | 1 |
| Chung, JS | 1 |
| Shin, HJ | 1 |
| Cho, GJ | 1 |
| Wang, SG | 1 |
| Lee, BJ | 1 |
| Cho, BM | 1 |
| Joo, YD | 1 |
| Sohn, CH | 1 |
| Nakata, A | 1 |
| Iwanami, Y | 1 |
| Ito, H | 1 |
| Takano, H | 1 |
| Nanjo, H | 1 |
| Morita, M | 1 |
| Toyoshima, H | 1 |
| Iino, K | 1 |
| Sasaki, H | 1 |
| Saito, N | 1 |
| Tsutsumida, A | 1 |
| Saito, A | 1 |
| Furukawa, H | 1 |
| Suzuki, K | 1 |
| Nishioka, T | 1 |
| Ikeda, Y | 2 |
| Yabuki, K | 1 |
| Mitake, D | 1 |
| Satake, B | 2 |
| Yanoma, S | 1 |
| Mizuno, H | 1 |
| Mizuno, T | 1 |
| Hiraiwa, A | 1 |
| Takada, N | 1 |
| Ueno, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Study of Toripalimab Monoclonal Antibody Combined With Gemcitabine/5--fluoropyrimidine in the Treatment of Advanced Cholangiocarcinoma[NCT03982680] | Phase 2 | 30 participants (Anticipated) | Interventional | 2019-07-13 | Recruiting | ||
| A Phase II/III Study Comparing Simultaneous Integrated Boost (SIB) Intensity Modulated Radiation Therapy (IMRT) With S1 Based SIB-IMRT Followed by Adjuvant Chemotherapy With S1 in Elderly Patients With Esophageal or Esophagogastric Cancer (3JECROG-P01)[NCT02979691] | Phase 2/Phase 3 | 350 participants (Anticipated) | Interventional | 2016-10-31 | Completed | ||
| Multicenter Phase II Study of Weekly Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Squamous Cell Cancer of the Head and Neck[NCT01645748] | Phase 2 | 35 participants (Actual) | Interventional | 2008-10-31 | Completed | ||
| Concurrent Radiotherapy and Weekly Chemotherapy of 5-fluorouracil and Cisplatin for Postoperative Locoregional Recurrence of Oesophageal Squamous Cell Carcinoma[NCT02325986] | Phase 2 | 46 participants (Anticipated) | Interventional | 2015-03-31 | Recruiting | ||
| Controlled Randomized Trial to Evaluate Efficacy of Adjuvant Chemotherapy Between S-1 and UFT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Phase III Study[NCT00336947] | Phase 3 | 500 participants (Anticipated) | Interventional | 2006-04-30 | Active, not recruiting | ||
| A Phase II Trial of Dose Escalated Proton Beam Therapy or Photon Therapy for Resectable and Unresectable Esophageal Cancer[NCT03234842] | Phase 2 | 0 participants (Actual) | Interventional | 2017-10-30 | Withdrawn (stopped due to non-accrual) | ||
| PhaseⅡSingle-center, Open-label, Exploratory Clinical Study of Apatinib in Combination With S1 for the Patients With Advanced Non-squamous Head and Neck Cancer[NCT02943252] | Phase 2 | 30 participants (Anticipated) | Interventional | 2016-10-31 | Recruiting | ||
| Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced Non-squamous Non-small Cell Lung Cancer[NCT03700333] | Phase 3 | 120 participants (Anticipated) | Interventional | 2018-10-20 | Not yet recruiting | ||
| A Prospective, Single-arm Study of Simultaneous Modulated Accelerated Radiotherapy Combined With S-1/DDP for Elderly Esophageal Squamous Cell Carcinoma.[NCT02606916] | Phase 2 | 42 participants (Actual) | Interventional | 2015-07-31 | Completed | ||
| A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer[NCT01874678] | 45 participants (Actual) | Interventional | 2011-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for oxonic acid and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Dru | 2017 |
[Squamous cell carcinoma of the anal canal showing pathological complete response after S-1 plus radiotherapy -a case report].
Topics: Antimetabolites, Antineoplastic; Anus Neoplasms; Biopsy; Carcinoma, Squamous Cell; Chemoradiotherapy | 2011 |
[A case of elderly advanced squamous cell lung carcinoma successfully treated with nedaplatin and S-1 combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Combinations; H | 2012 |
[Clinical efficacy of administration with S-1 alone for head and neck carcinoma].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2006 |
[Combination therapy with S-1 and CDDP for head and neck cancer].
Topics: Adult; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinom | 2006 |
[Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma].
Topics: Anorexia; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Ad | 2006 |
66 trials available for oxonic acid and Carcinoma, Epidermoid
| Article | Year |
|---|---|
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 2020 |
An Open-Label Single-Arm Phase II Study of Treatment with Neoadjuvant S-1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Comb | 2020 |
Phase I dose-escalation trial of S-1 combined with carbon-ion radiotherapy for sinonasal squamous cell carcinoma.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Combinations; Female; Heavy I | 2020 |
Comparative study of cisplatin-based definitive concurrent chemoradiotherapy with S-1 versus paclitaxel for unresectable locally advanced esophageal squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplat | 2017 |
Adherence and feasibility of 2 treatment schedules of S-1 as adjuvant chemotherapy for patients with completely resected advanced lung cancer: a multicenter randomized controlled trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lu | 2017 |
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2017 |
S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled phase II trial.
Topics: Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Drug Combinations; | 2017 |
Phase I/II Trial of Chemotherapy with Docetaxel, Cisplatin, and S-1 for Unresectable Advanced Squamous Cell Carcinoma of the Esophagus.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2018 |
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; C | 2018 |
Dynamics of blood neutrophil-related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non-small cell lung cancer: A hypothesis-generating study.
Topics: Adenocarcinoma; Aged; Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemother | 2019 |
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 2019 |
A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2019 |
Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squam | 2013 |
Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Antineoplastic Combined Chemothera | 2013 |
Phase I pharmacokinetic study of S-1 granules and nedaplatin for advanced head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Combinations; F | 2013 |
A phase I study of concurrent chemoradiotherapy using oral s-1 for head and neck cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Dose | 2014 |
Phase I study of nedaplatin prior to S-1 in patients with locally advanced head and neck squamous cell carcinoma.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Sch | 2013 |
Docetaxel/ TS-1 with radiation for unresectable squamous cell carcinoma of the esophagus--a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Es | 2014 |
Phase II study of concurrent chemoradiotherapy with S-1 in patients with stage II (T2N0M0) squamous cell carcinoma of the Pharynx or Larynx.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Combination | 2014 |
S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2015 |
Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC).
Topics: Adult; Aged; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Combinations; Female; Head and N | 2015 |
Randomized phase 2 trial of S1 and oxaliplatin-based chemoradiotherapy with or without induction chemotherapy for esophageal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 2015 |
Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; C | 2015 |
Critical evaluation of a prospective study of concurrent chemoradiotherapy with S-1 for early glottic carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Drug Combinations; Fem | 2015 |
A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; C | 2015 |
How long should we continue S-1 as adjuvant chemotherapy for squamous cell carcinoma of the head and neck?
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Sq | 2015 |
Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2015 |
Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Com | 2016 |
Efficacy and safety of S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3-dimensional conformal radiotherapy for newly diagnosed squamous cell carcinoma of the lung in elderly patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; C | 2016 |
Continuation maintenance therapy with S-1 in chemotherapy-naïve patients with advanced squamous cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carb | 2016 |
Concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Drug Combinations; | 2008 |
Outpatient chemotherapy with S-1 for recurrent head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2009 |
Phase II trial of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck: Japan Clinical Oncology Group Study (JCOG0706).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 2009 |
Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; | 2010 |
Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2010 |
Randomized phase II study of two different schedules of gemcitabine and oral S-1 in chemo-naïve patients with advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung | 2010 |
A multi-institution phase I/II trial of triweekly regimen with S-1 plus cisplatin in patients with advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Ce | 2010 |
Preoperative concurrent chemotherapy with S-1 and radiotherapy for locally advanced squamous cell carcinoma of the oral cavity: phase I trial.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamo | 2010 |
Phase I/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer.
Topics: Aged; Aged, 80 and over; Anemia; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administr | 2010 |
A randomized phase II study of a combination of docetaxel and S-1 versus docetaxel monotherapy in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy: results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma | 2010 |
Phase I study of S-1 plus nedaplatin in patients with advanced/recurrent head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin | 2010 |
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2011 |
Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capsul | 2011 |
Phase II trial of S-1 as second-line therapy in patients with advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Large Ce | 2011 |
A Phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical Stage II/III squamous cell carcinoma of anal canal (JCOG0903: SMART-AC).
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined C | 2011 |
An open-label, multicenter, three-stage, phase II study of s-1 in combination with cisplatin as first-line therapy for patients with advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2011 |
Docetaxel, nedaplatin, and S-1 (DGS) chemotherapy for advanced esophageal carcinoma: a phase I dose-escalation study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Dose-Res | 2011 |
Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplasti | 2012 |
Feasibility of concurrent chemoradiotherapy with S-1 administered on alternate days for elderly patients with head and neck cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemoradiotherap | 2012 |
[A phase II prospective randomized controlled trial of weekly paclitaxel combined with S-1 or fluorouracil for advanced gastric carcinoma].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diarrhea; | 2012 |
Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anorexia; Antimetabolites, Antineoplastic; Carcinoma, | 2013 |
Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Comb | 2013 |
S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; C | 2004 |
[Phase I study of concurrent radiotherapy with TS-1 and vitamin A (TAR Therapy) for head and neck cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dru | 2005 |
Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemot | 2005 |
[Clinical phase trial of concurrent chemoradiotherapy combined TS-1 and nedaplatin].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Moda | 2005 |
Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2005 |
[Clinical trial of chemotherapy identified according to chemosensitivity assay for oral cancer patients with unresectable recurrent lesions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedu | 2006 |
[Combination chemotherapy with S-1 and carboplatin for head and neck cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 2006 |
[Clinical phase I trial of concurrent chemo-radiotherapy with S-1 for T2NO glottic carcinoma].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Deglutit | 2006 |
[Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cispl | 2006 |
[Phase I study of concurrent radiotherapy with S-1 for oral squamous cell carcinoma].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; D | 2006 |
[Preoperative chemotherapy with S-1 and low-dose cisplatin for oral squamous cell carcinoma].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy | 2006 |
Multi-institutional phase II trial of S-1 in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Dose-Response Relat | 2008 |
[Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
Topics: Administration, Oral; Adult; Aged; Anorexia; Antimetabolites, Antineoplastic; Carcinoma, Squamous Ce | 1998 |
[Late phase II study of S-1 in patients with advanced head and neck cancer].
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug A | 2001 |
113 other studies available for oxonic acid and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Application of Evidence-Based Nursing Intervention in the Treatment of Advanced Squamous Cell Carcinoma of the Lung by Erlotinib Combined with Tegafur, Gimeracil, and Oteracil Potassium and Its Influence on Quality of Life.
Topics: Carcinoma, Squamous Cell; Erlotinib Hydrochloride; Evidence-Based Nursing; Humans; Lung; Oxonic Acid | 2021 |
[A Case of Metaplastic Squamous Cell Carcinoma of the Breast Successfully Treated with S-1].
Topics: Antimetabolites, Antineoplastic; Axilla; Biopsy, Large-Core Needle; Breast Neoplasms; Carcinoma, Squ | 2019 |
A pilot study of adjuvant chemotherapy with carboplatin and oral S-1 for patients with completely resected stage II to IIIA non-small cell lung cancer.
Topics: Adenocarcinoma of Lung; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; | 2020 |
Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Dis | 2021 |
The Immunological Impact of Chemotherapy on the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; B7-H1 Antigen; Carcinoma, Squamous Cell; Case | 2017 |
Impact of combined modality treatment with radiotherapy and S-1 on T2N0 laryngeal cancer: Possible improvement in survival through the prevention of second primary cancer and distant metastasis.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Combination | 2017 |
Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Combinations; Fema | 2018 |
A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2019 |
[Clinicopathological Evaluation of Preoperative Chemotherapy Containing S-1 as a Treatment for Patients with Oral Squamous Cell Carcinoma during Waiting Time for Surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Combinations; Humans; | 2019 |
Histopathological changes in tumor budding between biopsy and resected specimens from patients treated with preoperative S-1 chemotherapy for oral cancer.
Topics: Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Squamous Cell; Drug Combinations; Humans; Mouth | 2019 |
Salvage radiation therapy and chemoradiation therapy for postoperative locoregional recurrence of esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinosarcom | 2014 |
S-1 monotherapy as second- or third-line chemotherapy for unresectable and recurrent esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carc | 2013 |
Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells.
Topics: Administration, Metronomic; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carc | 2013 |
Outpatient oral chemotherapy with S-1 for unresectable or distant metastatic head and neck cancer.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug C | 2013 |
Chemoradiation using cisplatin and S-1 in locally advanced giant squamous cell carcinoma of the buttock.
Topics: Aged; Antineoplastic Agents; Buttocks; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cispla | 2014 |
Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Transport System ASC; Amino Acid Transport System y+; Ant | 2014 |
Oral S-1 in advanced cutaneous squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Combination | 2014 |
[A case of squamous cell carcinoma of the nipple skin successfully treated with S-1 alone].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Squamous Cell; | 2014 |
Clinical outcomes of nedaplatin and S-1 treatment with concurrent radiotherapy in advanced head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; | 2015 |
[Squamous cell carcinoma of the anal canal showing complete response after concurrent chemoradiotherapy and S-1 plus mitomycin C - a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Chem | 2014 |
Feasibility and toxicity of adjuvant chemotherapy using S-1 granules for local advanced squamous cell carcinoma of the head and neck.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemot | 2015 |
[Indication of alternate-day treatment with S-1 in patients with oral cancer].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Comb | 2015 |
A case report: pancreatic squamous cell carcinoma with effective response by S-1 therapy.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Combinations; Humans; Male; Ox | 2014 |
Evolution of a Lung-Sparing Strategy with Sleeve Lobectomy and Induction Therapy for Non-small Cell Lung Cancer: 20-Year Experience at a Single Institution.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Large | 2016 |
Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Car | 2016 |
Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2016 |
Comparison of Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; D | 2016 |
T-status and an oral fluoropyrimidine, S-1, adjuvant chemotherapy are prognostic factors in reduced-RADPLAT for resectable hypopharyngeal cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemoth | 2016 |
Clinical management of squamous cell carcinoma associated with sinonasal inverted papilloma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemor | 2017 |
Prognostic Factors and Multidisciplinary Postoperative Chemoradiotherapy for Clinical T4a Tongue Cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradioth | 2016 |
Adult T-cell leukemia/lymphoma in patients with head and neck cancer after S-1 chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; C | 2017 |
[A Case of Synchronous Esophageal and Gastric Cancer Successfully Treated Using Multimodal Therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chem | 2016 |
A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; China; Cispla | 2017 |
Squamous cell carcinoma of the extrahepatic bile duct with metachronous para-aortic lymph node metastasis successfully treated with S-1 plus cisplatin.
Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma, Squ | 2016 |
[A case report of S-1 single effective use as third-line chemotherapy and re-challenge in a recurrent squamous cell lung cancer patient].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; D | 2008 |
Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined | 2009 |
Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzylisoquinolines; Blotting, W | 2009 |
Clinical relevance of thymidylate synthase (TS) activity for S-1-based chemotherapy in squamous cell carcinoma of the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Admi | 2010 |
[Two cases of head and neck squamous cell carcinoma in which S-1 administration resulted in long-term sustained QOL].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Combination | 2009 |
S-1 mediates the inhibition of lymph node metastasis in oral cancer cells.
Topics: Animals; Antimetabolites, Antineoplastic; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tu | 2009 |
[Successful treatment results of S-1 administration in 2 patients, one with a remnant tumor of the larynx and metastatic tumors to the lung, and another with a metastatic tumor in the neck from the hypopharynx].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 2009 |
Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Adenosquamous; Carcinoma, Sq | 2009 |
[A case of effective chemoradiotherapy using S-1 and CDDP for left inguinal lymph node metastasis of anal canal carcinoma].
Topics: Administration, Oral; Aged; Anal Canal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anti | 2009 |
[Complete response by S-1 with multiple pulmonary metastases 4 years after lung resection-a case report].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Combinations; Humans; Lung Neo | 2009 |
Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Th | 2010 |
Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cis | 2010 |
Effects of lentinan alone and in combination with fluoropyrimidine anticancer agent on growth of human oral squamous cell carcinoma in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; | 2010 |
Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Ci | 2011 |
Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, S | 2011 |
[Efficacy of concomitant therapy with S-1, CDGP, and radiation for laryngeal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Th | 2010 |
Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Th | 2011 |
Successful S-1 monotherapy for chemorefractory thymic carcinoma.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Combinations; Drug Resistance, Neopl | 2011 |
Synchronous double primary lung cancers with different response to pemetrexed.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamo | 2011 |
[A case of multiple para-aortic lymph node metastases from squamous cell carcinoma of an unknown primary responding completely to chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Carcinoma, Squamous Cell; Cisplatin; Drug Com | 2011 |
[Evaluation of combination chemotherapy with oral S-1 administration followed by docetaxel by superselective intra-arterial infusion for patients with oral squamous cell carcinomas].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2011 |
Consecutive daily low-dose S-1 adjuvant chemotherapy after radical treatment for squamous cell carcinoma in head and neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemother | 2011 |
Stereotactic radiosurgery in combination with chemotherapy as primary treatment for head and neck cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2012 |
Retrospective analysis of third-line and fourth-line chemotherapy for advanced non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2012 |
S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Disease-Free Survival; Drug | 2011 |
[Clinical analyses of oral squamous cell carcinoma patients showing a complete response to chemotherapy with S-1 alone].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Combination | 2011 |
[A case report of chemoradiotherapy combined with S-1 responding to squamous cell carcinoma of the anal canal].
Topics: Aged; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; | 2011 |
Histopathological changes in parotid and submandibular glands of patients treated with preoperative chemoradiation therapy for oral cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Combinations; Female; | 2012 |
The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dr | 2012 |
Adjuvant chemotherapy with an oral fluoropyrimidine, S-1, following reduced RADPLAT in advanced laryngeal cancer.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, | 2012 |
[A resected case of complete response after treatment with S-1 for recurrent squamous cell carcinoma component of the breast].
Topics: Aged; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Squamous Cell; Combined Modality | 2012 |
A case of advanced cutaneous squamous cell carcinoma of the lower eyelid that was successfully treated with tegafur-gimeracil-oteracil potassium monotherapy.
Topics: Administration, Oral; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; | 2012 |
[A case of a geriatric patient with stage IV anal canal cancer showing complete response to chemoradiation therapy].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamo | 2012 |
[Long-term complete response to treatment with TS-1 in a patient with oropharyngeal squamous cell carcinoma].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combin | 2002 |
[A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality | 2003 |
[Combination therapy of fluoropyrimidine (TS-1) administration and selective intra-arterial cisplatin infusion for tongue carcinoma--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administra | 2003 |
[A case report of tongue squamous cell carcinoma showing a complete response to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squam | 2003 |
[A case of mandibular gingival cancer (T4) responding to concurrent chemoradiotherapy with TS-1].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administrat | 2003 |
[Remarkable response of simultaneous advanced esophageal and gastric cancer to combined chemotherapy with weekday-on/Weekend-off TS-1 plus biweekly cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Carcinoma, Squamo | 2003 |
[A case of advanced maxillary carcinoma with cervical lymph node metastases showing a complete response to the combination therapy of CDDP, TS-1 and radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuva | 2004 |
[Complete response in a case of advanced esophageal cancer treated by combined chemotherapy of TS-1 and CDDP with radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined | 2004 |
[A case of synchronous esophageal and gastric cancer successfully treated by combination TS-1/CDDP therapy with irradiation].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squ | 2004 |
[A case of neck metastasis from hypopharyngeal carcinoma successfully treated with TS-1].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combin | 2004 |
[An advanced case of squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to chemotherapy with TS-1].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administrat | 2004 |
[A case of metastatic esophageal cancer responding remarkably to combination chemotherapy of TS-1 and cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administra | 2004 |
Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Cell Survival; Combin | 2004 |
[A case of advanced cervical and upper thoracic esophageal carcinoma completely responding to chemoradiotherapy with TS-1 and cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modali | 2004 |
The syndrome of inappropriate antidiuretic hormone secretion associated with chemotherapy for hypopharyngeal cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; D | 2004 |
[A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Admi | 2004 |
[Preoperative chemotherapy with TS-1 and low dose cisplatin for oral squamous cell carcinoma patients--a preliminary study].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2005 |
[Combination therapy with TS-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Cl | 2005 |
[A case report of cancer of the lip--complete response by a neo-adjuvant chemotherapy using a novel method of TS-1 administration].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Administrati | 2006 |
[A case of a second cancer of metachronous multiple primary non-small cell lung cancer successfully treated with TS-1 and CDDP chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 2006 |
Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Dihydrouracil Dehydrogenase (NADP); Drug C | 2006 |
[A case of recurrent esophageal cancer responding to second-line chemotherapy of TS-1/docetaxel combination].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuva | 2006 |
[Combination chemotherapy of TS-1, docetaxel and CDDP produces a remarkable response in a patient with advanced esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel | 2006 |
[A case of advanced double cancer of the lung and stomach responding to combination chemotherapy of cisplatin and TS-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Admi | 2006 |
[Clinical efficacy of TS-1 in refractory bone recurrence of a postoperative squamous lung cancer patient].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Squamous Cell; Com | 2006 |
[An elderly patient with non-resectable lung cancer responding to TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug | 2006 |
[Complete response in a case of advanced esophageal and gastric double cancer treated by chemotherapy of TS-1 and low-dose cisplatin].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisp | 2006 |
S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Combinati | 2007 |
[Recurrent esophageal cancer with complete response to TS-1 chemotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Ther | 2007 |
[A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Squamous Cell; C | 2007 |
[Clinical evaluation of palliative chemotherapy with S-1 for oral cancer patients].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modalit | 2007 |
[A case of advanced oral squamous cell carcinoma responding to concurrent radiotherapy with S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Adm | 2007 |
[A case of maxillary sinus carcinoma showing long time survival after lung metastasis with administration of S-1 as tumor dormancy therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Adm | 2007 |
[A case of postoperative multiple pulmonary metastases of non-small-cell lung cancer successfully treated with S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combine | 2007 |
[Long-term results of S-1 administration as adjuvant chemotherapy for advanced head and neck cancer].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Administratio | 2007 |
[A case of oral squamous cell carcinoma responding to S-1].
Topics: Administration, Oral; Aged; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Biomarkers, Tumor; | 2007 |
Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma.
Topics: Aged; Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Combined Modali | 2007 |
[Severe advanced lower gingival carcinoma effectively reduced by chemoradiation with S-1--report of a case].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administr | 2007 |
Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 2008 |
[Evaluation of combination chemotherapy with S-1 and docetaxel for patients with oral squamous cell carcinomas].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2007 |
[A case of multidrug-resistant squamous cell lung carcinoma responding to S-1 plus CPT-11 combination chemotherapy].
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; | 2008 |
[Squamous cell carcinoma of the lower lip, completely responding to concurrent chemoradiotherapy with S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Th | 2008 |
[Concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; D | 2008 |
Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy | 2000 |
[Complete response in a case of simultaneous esophageal and gastric cancer treated by combined radiotherapy and chemotherapy of TS-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Admi | 2002 |
[A case of gastric cancer in the stomach wall used for mediastinal reconstruction after esophagectomy in which surgery was abandoned due to advanced age and complications but TS-1 was useful].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug | 2002 |